A Robust α-l-Fucosidase from Prevotella nigrescens for Glycoengineering Therapeutic Antibodies

Mu-Rong Kao,Tzu-Hsuan Ma,Hsiang-Yu Chou,Shu-Chieh Chang,Lin-Chen Cheng,Kuo-Shiang Liao,Jiun-Jie Shie,Philip J. Harris,Chi-Huey Wong,Yves S. Y. Hsieh
DOI: https://doi.org/10.1021/acschembio.4c00196
IF: 4.634
2024-06-25
ACS Chemical Biology
Abstract:Eliminating the core fucose from the N-glycans of the Fc antibody segment by pathway engineering or enzymatic methods has been shown to enhance the potency of therapeutic antibodies, especially in the context of antibody-dependent cytotoxicity (ADCC). However, there is a significant challenge due to the limited defucosylation efficiency of commercially available α-l-fucosidases. In this study, we report a unique α-l-fucosidase (PnfucA) from the bacterium Prevotella nigrescens that has a low...
biochemistry & molecular biology
What problem does this paper attempt to address?